HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 179 filers reported holding HERON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,058,000 | -49.2% | 166,024 | -46.1% | 1.50% | -54.9% |
| Q4 2018 | $7,983,000 | -18.0% | 307,737 | 0.0% | 3.32% | -12.7% |
| Q3 2018 | $9,740,000 | -9.4% | 307,737 | +11.2% | 3.80% | +4.3% |
| Q2 2018 | $10,751,000 | +10.7% | 276,729 | -21.3% | 3.64% | -20.5% |
| Q1 2018 | $9,708,000 | – | 351,729 | – | 4.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |